Incidence, Mortality, and Federal Research Funding by Cancer Type in the US

1

Federal cancer research funding distribution in the US does not align with disease burden, particularly for cancers with high lethality.
2

Lung cancers and pancreatic cancer have high mortality-to-incidence ratios, indicating most diagnoses result in death.
3

Breast cancer received $1.58 billion in NIH funding, while funding for SCLC and pancreatic cancer was significantly lower at $62 million and $440 million, respectively.
4

Cancers with limited advocacy often rely on federal funding, highlighting disparities in research investment based on historical progress and advocacy.
5

A composite framework for funding should integrate incidence with outcome-based measures to better address clinical needs and resource allocation.

1